These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 36238257)

  • 81. Disease Interventions Can Interfere with One Another through Disease-Behaviour Interactions.
    Andrews MA; Bauch CT
    PLoS Comput Biol; 2015 Jun; 11(6):e1004291. PubMed ID: 26047028
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A model-based economic analysis of pre-pandemic influenza vaccination cost-effectiveness.
    Halder N; Kelso JK; Milne GJ
    BMC Infect Dis; 2014 May; 14():266. PubMed ID: 24884470
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand.
    Huang QS; Wood T; Jelley L; Jennings T; Jefferies S; Daniells K; Nesdale A; Dowell T; Turner N; Campbell-Stokes P; Balm M; Dobinson HC; Grant CC; James S; Aminisani N; Ralston J; Gunn W; Bocacao J; Danielewicz J; Moncrieff T; McNeill A; Lopez L; Waite B; Kiedrzynski T; Schrader H; Gray R; Cook K; Currin D; Engelbrecht C; Tapurau W; Emmerton L; Martin M; Baker MG; Taylor S; Trenholme A; Wong C; Lawrence S; McArthur C; Stanley A; Roberts S; Rahnama F; Bennett J; Mansell C; Dilcher M; Werno A; Grant J; van der Linden A; Youngblood B; Thomas PG; ; Webby RJ
    Nat Commun; 2021 Feb; 12(1):1001. PubMed ID: 33579926
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Prediction of upcoming global infection burden of influenza seasons after relaxation of public health and social measures during the COVID-19 pandemic: a modelling study.
    Ali ST; Lau YC; Shan S; Ryu S; Du Z; Wang L; Xu XK; Chen D; Xiong J; Tae J; Tsang TK; Wu P; Lau EHY; Cowling BJ
    Lancet Glob Health; 2022 Nov; 10(11):e1612-e1622. PubMed ID: 36240828
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Influenza incidence overlapped with COVID-19 or under COVID-19 control measures.
    Shokri A; Moradi G; Moradpour F; Mohamadi Bolbanabad A; Younesi F; Daftarifard P; Ebrazeh A
    Immun Inflamm Dis; 2022 Aug; 10(8):e672. PubMed ID: 35894708
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Estimating the population effectiveness of interventions against COVID-19 in France: A modelling study.
    Ganser I; Buckeridge DL; Heffernan J; Prague M; Thiébaut R
    Epidemics; 2024 Mar; 46():100744. PubMed ID: 38324970
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Technical guidelines for seasonal influenza vaccination in China, 2019-2020].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov; 40(11):1333-1349. PubMed ID: 31838802
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A novel household-based patient outreach pilot program to boost late-season influenza vaccination rates during the COVID-19 pandemic.
    Fisher L; Loiacono MM; Payne N; Kelley T; Greenberg M; Charpentier M; Leblanc C; Sundaresan D; Bancroft T; Steffens A; Paudel M
    Influenza Other Respir Viruses; 2022 Nov; 16(6):1141-1150. PubMed ID: 36098249
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany.
    Böhmer MM; Walter D; Falkenhorst G; Müters S; Krause G; Wichmann O
    BMC Public Health; 2012 Oct; 12():938. PubMed ID: 23113995
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Evaluation of a Clinical Decision Support Strategy to Increase Seasonal Influenza Vaccination Among Hospitalized Children Before Inpatient Discharge.
    Orenstein EW; ElSayed-Ali O; Kandaswamy S; Masterson E; Blanco R; Shah P; Lantis P; Kolwaite A; Dawson TE; Ray E; Bryant C; Iyer S; Shane AL; Jernigan S
    JAMA Netw Open; 2021 Jul; 4(7):e2117809. PubMed ID: 34292335
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Dynamics of the COVID-19 epidemic in the post-vaccination period in Korea: a rapid assessment.
    Min KD; Tak S
    Epidemiol Health; 2021; 43():e2021040. PubMed ID: 34082498
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Vaccine effectiveness of live attenuated and trivalent inactivated influenza vaccination in 2010/11 to 2015/16: the SIVE II record linkage study.
    Simpson CR; Lone NI; Kavanagh K; Englishby T; Robertson C; McMenamin J; Wissman BV; Vasileiou E; Butler CC; Ritchie LD; Gunson R; Schwarze J; Sheikh A
    Health Technol Assess; 2020 Dec; 24(67):1-66. PubMed ID: 33256892
    [TBL] [Abstract][Full Text] [Related]  

  • 93. COVID-19 transmission driven by age-group mathematical model in Shijiazhuang City of China.
    Wei F; Zhou R; Jin Z; Huang S; Peng Z; Wang J; Xu X; Zhang X; Xu J; Bai Y; Wang X; Lu B; Wang Z; Xu J
    Infect Dis Model; 2023 Dec; 8(4):1050-1062. PubMed ID: 37706095
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Increased population susceptibility to seasonal influenza during the COVID-19 pandemic in China and the United States.
    Wang Q; Jia M; Jiang M; Cao Y; Dai P; Yang J; Yang X; Xu Y; Yang W; Feng L
    J Med Virol; 2023 Oct; 95(10):e29186. PubMed ID: 37855656
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Quantifying the rebound of influenza epidemics after the adjustment of zero-COVID policy in China.
    Lei H; Yang L; Yang M; Tang J; Yang J; Tan M; Yang S; Wang D; Shu Y
    PNAS Nexus; 2023 May; 2(5):pgad152. PubMed ID: 37215632
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Lifting COVID-19-associated non-pharmaceutical interventions: potential impact on notifications of infectious diseases transmitted from person to person in 2022 in Bavaria, Germany.
    Hausmann J; Dörre A; Katz K; van de Berg S
    Front Public Health; 2024; 12():1437485. PubMed ID: 39148653
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Using a Bayesian hierarchical approach to study the association between non-pharmaceutical interventions and the spread of Covid-19 in Germany.
    Khazaei Y; Küchenhoff H; Hoffmann S; Syliqi D; Rehms R
    Sci Rep; 2023 Nov; 13(1):18900. PubMed ID: 37919336
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Potential impact of introducing vaccines against COVID-19 under supply and uptake constraints in France: A modelling study.
    Coudeville L; Jollivet O; Mahé C; Chaves S; Gomez GB
    PLoS One; 2021; 16(4):e0250797. PubMed ID: 33909687
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Effect of Non-pharmaceutical Interventions on COVID-19 in Rwanda: An Observational Study.
    Rwagasore E; Nsekuye O; Rutagengwa A; El-Khatib Z
    J Epidemiol Glob Health; 2023 Jun; 13(2):239-247. PubMed ID: 36892779
    [TBL] [Abstract][Full Text] [Related]  

  • 100. How the COVID 19 pandemic will shape influenza public health initiatives: The UK experience.
    Ashraf M; Rajaram S; English PM
    Hum Vaccin Immunother; 2022 Nov; 18(5):2056399. PubMed ID: 35435806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.